Inhibition of MRP1-mediated efflux in human erythrocytes by mono-anionic bile salts

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3173-3178

  Mrówczynska, Lucyna ^a   Bobrowska Hägerstrand, Malgorzata ^b   Wróbel, Anna ^c   Söderström, Thomas ^b,d   Hägerstrand, Henry ^b  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Cell shape; Detergent; Erythrocyte membrane; Haemolysis; Multidrug resistance protein (MRP); Phospholipid translocation

Indexed keywords

2',7' BIS(CARBOXYPROPYL) 5(6) CARBOXYFLUORESCEIN; BILE SALT; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; DETERGENT; FLUORESCEIN DERIVATIVE; GLYCOCHOLIC ACID; GLYCODEOXYCHOLIC ACID; LITHOCHOLIC ACID; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHATIDYLSERINE; PHOSPHOLIPID; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ARTICLE; CHEMICAL STRUCTURE; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE SHAPE; HEMOLYSIS; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL;

4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; ANIONS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; CELL SHAPE; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLUORESCEINS; FLUOROMETRY; HEMOLYSIS; HUMANS; INHIBITORY CONCENTRATION 50; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHOSPHATIDYLSERINES;

EID: 23344432647     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Haimeur A, Consei G, Deeley RG and Cole SP: Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1). Mol Pharmacol 65: 1375-1385, 2004.
2. Bobrowska-Hägerstrand M, Wróbel A, Mrówczyńska L, Söderström T and Hägerstrand H: Modulation of MRP-like efflux activity in human erythrocytes caused by membrane perturbing agents. Mol Membr Biol 20: 255-259, 2003.
3. Bobrowska-Hägerstrand M, Wróbel A, Rychlik B, Bartosz G, Söderström T, Shirataki Y, Motohashi N, Molnár J, Michalak K and Hägerstrand H: Monitoring of MRP-like activity in human erythrocytes - inhibitory effect of isoflavones. Blood Cells Mol Dis 27: 894-900, 2001.
4. Isomaa B, Hägerstrand H and Paatero G: Shape transformation induced by amphiphiles in erythrocytes. Biochim Biophys Acta Biomembranes 899: 93-103, 1987.
5. Hägerstrand H, Holmström T, Bobrowska-Hägerstrand M, Eriksson J and Isomaa B: Amphiphile-induced phosphatidylserine exposure in human erythrocytes. Mol Membr Biol 15: 89-95, 1998.
6. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G and Keppler D: Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56: 988-994, 1996.
7. Rychlik B, Balcerczyk A, Klimczak A and Bartosz G: The role of multidrug resistance protein 1 (MRP1) in transport of fluorescent anions across the human erythrocyte membrane. J Membr Biol 194: 79-90, 2003.
8. Hollo Z, Homolya L, Hegedus T and Sarkadi B: Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Lett 383: 99-104, 1996.
9. Rappa G, Lorico A, Flavell RA and Sartorelli AC: Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57: 5232-5237, 1997.
10. Dekkers DW, Comfurius P, Schroit AJ, Bevers EM and Zwaal RF: Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 37: 14833-14837, 1998.
11. Kamp D and Haest CWM: Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane. Biochim Biophys Acta Biomembranes 1372: 91-101, 1998.
12. DeCleves X, Regina A, Laplanche JL, Roux F, Boval B, Launay JM and Scherrmann JM: Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes. J Neurosc Res 60: 594-601, 2000.
13. Klokouzas A, Barrand MA and Hladky SB: Effects of clotrimazole on transport mediated by multidrug resistance associated protein 1 (MRP1) in human erythrocytes and tumour cells. Eur J Biochem 268: 6569-6577, 2001.
14. McAleer MA, Breen MA, White NL and Matthews N: pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem 274: 23541-23548, 1999.
15. Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E. Balzarini J and Borst P: Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci 97: 7476-7481, 2000.
16. Broughton G: Chenodeoxycholate: the bile acid. The drug. A review. Am J Med Sci 307: 54-63, 1994.
17. Thompson MB: Bile acids in the assessment of hepatocellular function. Toxicol Pathol 24: 62-71, 1996.
18. Bartosz G, Sies H and Akerboom TP: Organic anions exhibit distinct inhibition patterns on the low-Km and high-Km transport of S-(2,4-dinitrophenyl) glutathione through the human erythrocyte membrane, Biochem J 292: 171-174, 1993.
19. Loe DW, Almquist KC, Cole SP and Deeley RG: ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem 271: 9683-9689, 1996.
20. Keppler D, Leier I and Jedlitsschky G: Transport of glutathione conjugates and glucorunides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378: 787-791, 1997.
21. Heijn M, Hooijberg JH, Scheffer GL, Szabo G, Westerhoff HV and Lankelma J: Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim Biophys Acta 1326: 12-22, 1997.
22. Keppler D, Jedlitschky G and Leier I: Transport function and substrate specificity of multidrug resistance protein. Meth Enzym 292: 607-616, 1998.
23. Armstrong M and Carey MC: The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities. J Lipid Res 23: 70-80, 1982.
24. Güldütuna S, Zimmer G, Imhof M, Bhatti S, You T and Leuschner U: Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroent 104: 1736-1744, 1993.
25. Lamcharfi E, Cohen-Solal C, Parquet M, Lutton C, Dupre J and Meyer C: Determination of molecular associations of some hydrophobic and hydrophilic bile acids by infrared and Raman spectroscopy. Eur Biophys J 25: 285-291, 1997.
26. Heuman DM, Pandak WM, Hylemon PB and Vlahcevic ZR: Conjugates of urodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 14: 920-926, 1991.
27. Hägerstrand H, Kralj-Iglic V, Fosnaric M, Bobrowska-Hägerstrand M, Wróbel A, Mrówczyńska L, Söderström T and Iglic A: Endovesicle formation and membrane perturbation induced by polyoxyethyleneglycolalkylethers in human erythrocytes. Biochim Biophys Acta Biomembranes 1665: 191-200, 2004.
28. Sheetz MP and Singer SJ: Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci 71: 4457-4461, 1974.
29. Iglic A: A possible mechanism determining the stability of spiculateds red blood cells. J Biomechanics 30: 35-40, 1997.
30. Billington D and Coleman R: Effects of bile salts on human erythrocytes plasma membrane vesiculation, phospholipid solubilization and their possible relationships to bile secretion. Biochim Biophys Acta 50: 33-47, 1978.
31. Kamp F and Hamilton JA: Movement of fatty acids, fatty acid analogues, and bile acids across phospholipid bilayers. Biochemistry 32: 11074-11086, 1993.
32. Bessis M: Red cell shapes. An illustrated classification and its rationale. In: Red Cell Shape; Physiology, Pathology, Ultrastructure. Bessis M, Weed RI and Leblond PF (eds.). Spinger-Verlag, Heidelberg, pp. 1-24, 1973.
33. Heuman DM: Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lip Res 30: 719-730, 1989.
34. Lamcharfi E, Meyer C and Lutton C: Rationalization of the relative hydrophobicity of some common bile acids by infrared and raman spectroscopy. Biospectroscopy 3: 393-401, 1997.
35. Gu JJ, Hofmann AF, Ton-Nu HT, Schteingart CD and Mysels KJ: Solubility of calcium salts of unconjugated and conjugated natural bile acids. J Lipid Res 33: 635-646, 1992.
36. Lucangioli S, Carducci CN, Tripodi VP and Kenndler E: Retention of bile salts in micellar electrokinetic chromatography: relation of capacity factor to octanol-water partition coefficient and critical micellar concentration. J Chromat 765: 113-120, 2001.